• Something wrong with this record ?

Transcervical microwave ablation in type 2 uterine fibroids via a hysteroscopic approach: analysis of ablation profiles

G. Zia, J. Sebek, J. Schenck, P. Prakash

. 2021 ; 7 (4) : . [pub] 20210601

Language English Country Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc22012413

Type 2 uterine fibroids are challenging to resect surgically as ≥ 50% volume of myoma lies within the myometrium. A hysteroscopic approach for ablating fibroids is minimally-invasive, but places a considerable burden on the operator to accurately place the ablation applicator within the target. We investigated the sensitivity of transcervical microwave ablation outcome with respect to position of the ablation applicator within 1 - 3 cm type 2 fibroids.Methods:A finite element computer model was developed to simulate 5.8 GHz microwave ablation of fibroids and validated with experiments inex vivotissue. The ablation outcome was evaluated with respect to applicator insertion angles (30°, 45°, 60°) , depth and offset from the fibroid center (±2 mm for 3 cm fibroid and ±1 mm for 1 cm fibroid) with 35 W and 15 W applied power for 3 cm and 1 cm fibroids, respectively. Power deposition was stopped when thermal dose of 40 cumulative equivalent minutes at 43 °C (CEM43) was accrued in adjacent myometrium.Results:Within the range of all evaluated insertion angles, depths and offsets, the ablation coverage was less sensitive to variation in angle as compared to depth and offset, and ranged from 34.9 - 83.6% for 3 cm fibroid in 140 - 400 s and 34.1 - 67.9% for 1 cm fibroid in 30 - 50 s of heating duration. Maximum achievable ablation coverage in both fibroid cases reach ∼ 90% if thermal dose is allowed to exceed 40 CEM43 in myometrium.Conclusion:The study demonstrates the technical feasibility of transcervical microwave ablation for fibroid treatment and the relationship between applicator position within the fibroid and fraction of fibroid that can be ablated while limiting thermal dose in adjacent myometrium.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22012413
003      
CZ-PrNML
005      
20220506131533.0
007      
ta
008      
220425s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1088/2057-1976/abffe4 $2 doi
035    __
$a (PubMed)33975302
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Zia, Ghina $u Department of Electrical and Computer Engineering, Kansas State University, Manhattan, Kansas, United States of America $1 https://orcid.org/0000000302641533
245    10
$a Transcervical microwave ablation in type 2 uterine fibroids via a hysteroscopic approach: analysis of ablation profiles / $c G. Zia, J. Sebek, J. Schenck, P. Prakash
520    9_
$a Type 2 uterine fibroids are challenging to resect surgically as ≥ 50% volume of myoma lies within the myometrium. A hysteroscopic approach for ablating fibroids is minimally-invasive, but places a considerable burden on the operator to accurately place the ablation applicator within the target. We investigated the sensitivity of transcervical microwave ablation outcome with respect to position of the ablation applicator within 1 - 3 cm type 2 fibroids.Methods:A finite element computer model was developed to simulate 5.8 GHz microwave ablation of fibroids and validated with experiments inex vivotissue. The ablation outcome was evaluated with respect to applicator insertion angles (30°, 45°, 60°) , depth and offset from the fibroid center (±2 mm for 3 cm fibroid and ±1 mm for 1 cm fibroid) with 35 W and 15 W applied power for 3 cm and 1 cm fibroids, respectively. Power deposition was stopped when thermal dose of 40 cumulative equivalent minutes at 43 °C (CEM43) was accrued in adjacent myometrium.Results:Within the range of all evaluated insertion angles, depths and offsets, the ablation coverage was less sensitive to variation in angle as compared to depth and offset, and ranged from 34.9 - 83.6% for 3 cm fibroid in 140 - 400 s and 34.1 - 67.9% for 1 cm fibroid in 30 - 50 s of heating duration. Maximum achievable ablation coverage in both fibroid cases reach ∼ 90% if thermal dose is allowed to exceed 40 CEM43 in myometrium.Conclusion:The study demonstrates the technical feasibility of transcervical microwave ablation for fibroid treatment and the relationship between applicator position within the fibroid and fraction of fibroid that can be ablated while limiting thermal dose in adjacent myometrium.
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    12
$a leiomyom $x chirurgie $7 D007889
650    12
$a mikrovlny $7 D008872
650    _2
$a myometrium $7 D009215
650    _2
$a radiofrekvenční ablace $7 D000078703
655    _2
$a časopisecké články $7 D016428
700    1_
$a Sebek, Jan $u Department of Electrical and Computer Engineering, Kansas State University, Manhattan, Kansas, United States of America $u Department of Circuit Theory, Czech Technical University in Prague, Prague, Czech Republic $1 https://orcid.org/0000000221166697 $7 xx0214491
700    1_
$a Schenck, Jessica $u Hologic, Inc., Marlborough, Massachusetts, United States of America
700    1_
$a Prakash, Punit $u Department of Electrical and Computer Engineering, Kansas State University, Manhattan, Kansas, United States of America
773    0_
$w MED00208693 $t Biomedical physics & engineering express $x 2057-1976 $g Roč. 7, č. 4 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33975302 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506131525 $b ABA008
999    __
$a ok $b bmc $g 1789839 $s 1163614
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 7 $c 4 $e 20210601 $i 2057-1976 $m Biomedical physics & engineering express $n Biomed Phys Eng Express $x MED00208693
LZP    __
$a Pubmed-20220425

Find record

Citation metrics

Archiving options